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Following the South African case, Treatment Action Campaign and Others v Minister of Health and Others, the use of
‘pilot’ studies to investigate interventions already proven efficacious, offered free of charge to government, but
confined by the government to a small part of the population, may violate children’s right to health, and the negative
duty on governments not to prevent access to treatment. The applicants challenged a government decision to offer
Nevirapine in a few pilot sites when evidence showed Nevirapine significantly reduced HIV transmission rates and
despite donor offers of a free supply. The government refused to expand access, arguing they needed to collect more
information, and citing concerns about long-term hazards, side effects, resistance and inadequate infrastructure. The
court ruled this violated children’s right to health and asked the government to immediately expand access. Cluster
randomized trials involving children are increasingly popular, and are often used to reduce ‘contamination’: the
possibility that members of a cluster adopt behavior of other clusters. However, they raise unique issues insufficiently
addressed in literature and ethical guidelines. This case provides additional crucial guidance, based on a common
human rights framework, for the Kenyan government and other involved stakeholders. Children possess special rights,
often represent a ‘captive’ group, and so motivate extra consideration. In a systematic review, we therefore investigated
whether cluster trial designs are used to prevent or delay children’s access to treatment in Kenya or otherwise
inconsistently with children’s right to health as outlined in the above case. Although we did not find state sponsored
cluster trials, most had significant public sector involvement. Core obligations under children’s right to health were
inadequately addressed across trials. Few cluster trials reported rationale for cluster randomization, offered post- trial
access or planned to implement successful interventions. A small number of trials may have unnecessarily evaluated
proven interventions, offered their control arm trial conditions worse than local standards of care or evaluated
interventions ostensibly worse than local standards of care. Further research is required to establish if children’s right to
health in cluster trials is well understood and to explain why some obligations are unmet.
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Cluster randomized trials (cluster trials) are trials that
randomly allocate interventions to intact groups or clus-
ters of people such as schools or hospitals but collect in-
formation from individuals. In comparison, individually
randomized control trials (RCTs) randomly allocate in-
terventions directly to individual participants [1]. They
are sometimes referred to as pilot studies, community
based trials, knowledge translation trials and implemen-
tation trials.* Correspondence: elizabeth.oduwo.11@ucl.ac.uk
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article, unless otherwise stated.Traditionally, cluster trial designs are used to assess ef-
fectiveness and feasibility of new interventions for specific
settings, compared with RCTs, which assess efficacy of in-
terventions. They are increasingly popular and important
for sub Saharan Africa, where they can be used to address
widespread and serious health challenges such as maternal
and infant mortality, malaria, and HIV/AIDS, within se-
verely restricted health resources, to develop interventions
suitable for the environment.
Before publication of the Ottawa Statement on the
ethical design and conduct of cluster randomized trials in
2012 (Ottawa Statement) [2], there was little otherCentral Ltd. This is an Open Access article distributed under the terms of the
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legal requirements for cluster trials conducted in this
region. The Guidelines for the Conduct of Biomedical
Research involving Human Research Subjects in Kenya
(Kenyan Guidelines) published in 2004 cover all research
involving participants but have no specific provisions for
cluster randomized trials [3].
Yet, cluster trials raise unique issues which include, but
are not limited to, inadequate reporting and rationale for
cluster trials, incorrect identification of participants and
cluster units, difficulties in ethics review and achieving in-
formed consent, challenges with benefit harm assessment,
and with protection of vulnerable participants, issues
which are now receiving more attention [1,4-6].
Cluster trials in sub Saharan Africa encounter particu-
lar legal challenges associated with research in develop-
ing countries that largely remain unresolved and may be
exacerbated by cluster trials and by the involvement of
children. Key contested issues in this region include
questions about justification for studies, standard of care
offered by trials given prevalent low and unmet stan-
dards, and questions about the assessment of harms and
benefits in marginalized or vulnerable communities, and
about post trial access to successful interventions [7-10].
Host communities and stakeholders in the developing
world are increasingly concerned with justice in research
and the inevitable questions include how to equitably
share the benefits and burdens of research and provide
access to successful interventions [7-10]. As cluster trial
designs are not well understood, ethical implications of
children’s participation are not well understood and
given the prevalence of ethical issues in sub Saharan Africa,
children are particularly at risk of harm [11].
Children’s participation is a concern because they have
a limited capacity to consent, rely on their legal guard-
ians and thus may be exploited in cluster trials as in
some cases, their legal guardians are not directly in-
volved. In addition, children in sub Saharan Africa bear
a heavy disease burden, their needs are highly prioritized
and more cluster trials are likely to be designed and im-
plemented to address their situation; this justifies a spe-
cial examination of legal framework surrounding their
participation and the use of cluster trials.
With individually randomized control trials in Kenya,
research is justified when thresholds for equipoise are
obtained; that is when there is genuine disagreement
among the scientific community as to whether the new
intervention is better than the available therapy, and when
the benefits of participation are reasonable or outweigh the
risks of participation for individual participants, and when
control groups are offered similar or comparable standard
of care that would be otherwise be available outside the
study. All studies involving non-therapeutic interventions
should minimize their associated risks consistently withsound scientific design and these risks should be reasonable
in relation to anticipated gains [3].
Where children are involved, Kenyan Guidelines re-
quire studies to justify children’s inclusion and to seek
consent from their legal guardian. Research where inter-
ventions are intended to offer direct benefits to the child
should offer conditions to the control group that are as
advantageous as available alternatives whereas studies
not intended to offer therapeutic benefits, should involve
minimal risk which should also be commensurate with
the knowledge to be gained [3].
However, the above requirements, as well as other
guidelines are difficult to interpret even in the context of
RCTs, and their application to cluster trials involving
children in Kenya is yet to be discussed. Little is known
about the extent to which cluster trials involving chil-
dren are used and why. The recent Ottawa Statement
addresses some of the ethical issues raised by cluster tri-
als, but have yet to be applied, adapted or discussed in
the research context in sub Saharan Africa. The presence
of vulnerable participants is noted as a special issue for
cluster trials, but guidance on additional protection for
vulnerable groups is left to researchers and ethics review
committees [11].
Additional guidance can be drawn from children’s right
to health, and would be compatible with current ethical
frameworks for cluster trials as both Kenyan Guidelines
and Ottawa Statement recommend that guidance for re-
search and cluster trials should be read in light of local
and international guidelines and law.
While children are one population among vulnerable
populations requiring additional protection under ethical
guidelines for research and under law, they are well recog-
nized as a special group in Sub Saharan Africa and have a
special right to health under local and international law,
policy and guidelines for research which changes ethical
requirements in cluster trials. Their special right to health
is based on their vulnerability and weight and urgency of
their health needs. Children in sub Saharan Africa are es-
pecially vulnerable because they face the very basic threat
of survival (1). A recent World Health Report shows a
third of all children are born in this region, and it is esti-
mated that one out of nine children will die before they
reach the age of five as compared to one in sixteen chil-
dren in other regions, which is only a slight improvement
over recent years [12].
Arguably, children’s claim to special protection has a
strong moral impetus; a large number and significant
proportion of the world’s population and Kenya’s popu-
lation are at risk, they have little capacity to avoid or
counter these dangers and their claim is more urgent as
they face basic survival threats in comparison to other
vulnerable adult populations in sub Saharan Africa who
have survived their childhood.
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they claim a larger share of resources and attention to ad-
dress their circumstances, both in terms of healthcare and
research with an emphasis on primary healthcare and ser-
vices, and also this very basic threat to survival motivates
their claim for special consideration and additional protec-
tion as expressed in numerous international and local law,
instruments and policies [13-16].
Children’s claim for additional and special protection
in the context of health and research, which are often in
synergy with arguments for additional protection for
vulnerable participants within ethical guidelines for re-
search, are crucial for the ethical framework for cluster
trials. They impose additional obligations on stake-
holders involved in cluster trials and increase the protec-
tion for participant children and the wider population of
children.
The implications of children’s special right to health
in cluster trials are best expressed by the singular South
African case of Treatment Action Campaign and Others
v Minister of South Africa and Others (Treatment Ac-
tion Campaign case) which was resolved by a South
African Constitutional Court in 2002 [17]. The court
looked into claims brought forward under children’s
right to health on behalf of children outside a govern-
ment ‘research program’ who wanted access to an es-
sential medicine restricted to pilot sites and questioned
the justification presented by the government about the
need for further research using pilot studies. This paral-
lels concerns about trial conditions for control groups
and access to successful interventions for the wider
population as well as questions about the justification
for cluster trials with children.
The case began when applicants led by Treatment Ac-
tion Campaign, a local HIV/AIDS advocacy group, sued
South African health authorities, arguing against their
decision to offer Nevirapine only in pilot sites when evi-
dence showed Nevirapine significantly reduced chances
of transmission of HIV virus from mother to child, when
donors offered five years free supply of Nevirapine as
this was against children’s right to health and right to life
as outlined in the South African Constitution and vari-
ous other international instruments ratified by the South
African Government including the United Nations Inter-
national Covenant of Social and Economic Rights. The
intervention in question, Nevirapine, involved a single
dosage given to HIV positive expectant women during
delivery as well a dose to the newborn child and this
served to prevent HIV transmission from mother to
child during childbirth. A large population was in need
of this intervention and had no other alternative means
to prevent HIV transmission to newborn children.
On the other hand, health authorities refused to expand
access to Nevirapine beyond a few pilot sites arguing theywere conducting further research and needed to collect
more information about the effectiveness of offering Nevi-
rapine on a wide scale and within a more comprehensive
HIV/AIDS program and citing concerns about costs,
feasibility of a program to provide substitutes for breast
milk to prevent future transmission during early years, in-
sufficient infrastructure, and possibilities that a wide scale
resistance to Nevirapine could develop. The court ruled in
favour of the applicants and the government appealed this
decision at a South African constitutional court. In the
Appeal, health authorities argued that the applicants
wrongly sought to impose obligations on the government,
which were primarily the responsibility of parents. A con-
stitutional court dismissed this argument and government
defence and held children’s constitutional right to health
primarily imposed obligations on the Government in this
instance. A similar constitutional claim for children’s right
to health in other countries may impose obligations on
the other governments.
The court ruled out pilot studies artificially restricting
access to Nevirapine and asked the government to im-
mediately expand access to affected children. This deci-
sion clarified the position on several issues including the
acceptable rationale for cluster trials, the evidence gap of
efficacy and effectiveness required for further research
and particularly for cluster trials, trial conditions and
standard of care to be offered to all arms, and post-trial
access to beneficial interventions. The court found that
benefits of Nevirapine far outweighed harms for affected
children, as further delay would mean many more chil-
dren born with HIV/AIDS. Efficacy of Nevirapine was
established and acceptable as it significantly reduced
chances of children being born HIV positive. The af-
fected population had no other alternatives and faced a
short life of suffering. Extra capacity to make Nevirapine
available on a wide scale could be easily created if
needed.
The claim for children’s special right to health was based
on the South African bill of rights which provides in
Section 27(1) that ‘Everyone has the right to access to -…
(a) health care services including reproductive health care’
and in Section 28(1) ‘Every child has the right -… (c) to
basic nutrition, shelter, basic heath care services and social
services’ [18]. The Convention of the Rights of the Child
and the International Covenant on Economic, Social, and
Cultural Rights were also cited to support this interpret-
ation of children’s right to health [14,19].
Parallels can be drawn with the situation in Kenya
where children’s special right to health in Kenya was first
outlined in Children’s Act of 2001 of Kenya, which pro-
vides in Section 3, ‘The Government shall take steps to
the maximum of the available resources with a view to
achieving progressively the full realization of the rights
of the child’, in Section 4(1), ‘Every child shall have the
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the government and the family to ensure the survival
and the development of the child,’ and in Section 9,
‘Every child shall have a right to health and medical care,
the provision of which shall be the responsibility of the
parents and the Government’ [20]. In addition, Section 5
on non discrimination provides that ‘no child shall be
discriminated on’ [20].
In addition, Kenya has similarly ratified the Conven-
tion of Rights of the Child, which provides in Article
24.1 ‘State parties recognize the right of the child to the
enjoyment of the highest attainable standard of health
and to facilities for the treatment of illnesses and re-
habilitation of health. State parties shall strive to ensure
that no child is deprived of his or her right of access to
such healthcare services’. Furthermore, in Article 24.2,
state parties are obliged to take particular measures ‘(a)
to diminish infant mortality’ and ‘(b) to ensure the
provision of necessary medical assistance and healthcare
to all children with an emphasis on the development of
primary healthcare’ [14].
If these provisions are read together with the require-
ment in Kenyan Guidelines that research with children
should provide participants with at least the available
standard of care, the operative standard of healthcare for
children is basic or essential healthcare [3.14,15,20]. This
is reinforced by the long standing government policy of
free basic healthcare for children under five [21].
Section 53(1)(c) of Kenya’s 2010 Constitution is more
specific ‘Every child has the right to the basic nutrition,
shelter and healthcare’ and is almost verbatim to South
Africa’s Constitution in Section 28(1) that “Every child
has the right to basic nutrition, basic healthcare services
and social services’ and this would affect cluster trials
from 2010 going forward [22]. In comparison, adults are
constitutionally guaranteed only the right to emergency
medical care, although an argument could be made for
women’s constitutional right to access reproductive
healthcare and maternal healthcare in Kenya.
Treatment Action Campaign and Others v Minister of
Health and Others set out the general foundation of
children’s special right to health in the context of cluster
trials and outlined some of the obligations. However, a
more comprehensive reading drawn from the standard
interpretation of human rights adopted in international
documents, which defines three types of obligations for
state parties, the duty to respect, protect and fulfill hu-
man rights, and more fully describes the obligations for
government and other stakeholders involved in cluster
trials [15,23].
In brief, the duty to respect the human right to health
imposes a negative duty on governments to refrain from
activities and actions that deny or limit equal access to the
right to health for all parties. The duty to protect the rightto health imposes an obligation on governments to take
measures to ensure equal access to healthcare and health
related services and this includes an obligation for govern-
ment to ensure third parties do not limit equal access to
healthcare and related services [15].
The duty to fulfill the right to health imposes an obli-
gation on governments to progressively realize the right
to health through legal, political systems and through a
national health policy and provision of adequate health-
care services. The duty to fulfill and facilitate the right
to health also includes an obligation to take positive
measures to ensure individuals and communities enjoy
the right to health. These types of duties will impose
various obligations in cluster trials.
The duty to respect children’s right to health imposes
a negative obligation on government not to use cluster
randomized trial designs artificially to withhold access
to healthcare from children in any arm. This obligation
is stronger in the case of interventions offering essential
or basic health care, where the delay results in grave
consequences and where affected children have few
other alternatives.
Under the duty to respect children’s right to health,
governments are obliged to ensure children have equal
access to healthcare and related services [15]. This rules
out government sponsored cluster trials that do not
offer trial conditions comparable to the local available
standard of care, as this would discriminate against one
group of children. As children are entitled to basic or
essential healthcare under the Kenyan Constitution,
Convention on Rights of the Child and General com-
ment 14, they should be offered the available standard
of care under the Kenyan Guidelines, ruling out rules
out all cluster trials offering children less than the
standard of care in any arm.
Furthermore, children’s right to health imposes an ob-
ligation on governments not to take regressive measures
in relation to health unless these are deliberately taken
and, in such cases, governments will have the burden of
providing justification and showing due consideration
[15]. This rules out cluster trials assessing interventions
offering less than the standard of care without adequate
prior justification and consideration.
The obligation to respect and protect children’s right
to health rules out all cluster trials where there is suffi-
cient evidence and consensus within the relevant scien-
tific community about effectiveness and efficacy of the
intervention in question, and where the needs of target
children are pressing because such trials unnecessarily
restrict or delay children’s access to healthcare, particu-
larly where delays in implementation of effective inter-
ventions cause significant harm, such as in the above
case where the intervention could have prevented HIV
infection [15].
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ments to prevent third parties from infringing children’s
special right to health in cluster trials. This duty natur-
ally falls on ethics review committees who are mandated
by government to review cluster trials. Under this obli-
gation and mandate, ethics review committees will gen-
erally ensure children’s special right to health is not
violated in terms the prior evidence of efficacy and ef-
fectiveness presented by the protocol, the standard of
care offered to control groups and access to successful
interventions. In turn, under the duty to protect chil-
dren, third party independent cluster trials and other
organizations involved in cluster trials such as non-
governmental organizations, charities, international
sponsors, international development agencies and insti-
tutions will have a similar obligation not to violate chil-
dren’s right to health and address aspects of standard of
care, prior evidence of efficacy, and rationale.
Under the duty to fulfill children’s right to health, gov-
ernments are obliged to provide, facilitate and promote
children’s right to health, at a minimum of basic health-
care, adequate nutrition and shelter [15,22]. Thus gov-
ernments are required to roll out interventions with
proven efficacy, an obligation which is stronger when in-
terventions provide basic healthcare and where the ben-
efits are substantial and the risks faced serious or
irreparable. This government obligation also applies to
successful interventions assessed by independent cluster
trials, which should be rolled out by government to
wider populations of children with as little delay as pos-
sible, with priority given to those interventions offering
basic healthcare to children.
The obligation to fulfill children’s right to health has im-
plications on costs and feasibility of interventions. All
cluster trials should consider viability of their interven-
tions, assess cost elements and resources required, so as
to minimize children’s research burden, maximize re-
search opportunities and expedite access to healthcare.
The obligation to fulfill also affects justification of cluster
trials, some cluster trials are justified because they look
into aspects of feasibility and effectiveness of proven inter-
ventions and, as such, their justification should clearly
show that implementation is within reach, otherwise clus-
ter trials involving children may be futile from a right to
health perspective. Government sponsored cluster trials
will have an obligation towards all children and should roll
out successful interventions for the wider population
while independent cluster trials have an obligation to-
wards participating children and have a duty to roll out
successful interventions within control groups. The obli-
gation to fulfill children’s right to health also requires gov-
ernments to promote and facilitate cluster trial designs
where appropriate, as a means of progressively realizing
children’s right to health.In summary, children’s special right to health provides
additional ethical guidance and clarification in areas that
are traditionally problematic in research in resource re-
stricted areas and with vulnerable populations. Cluster
trialists are obliged to offer trial conditions equivalent to
local standards of care, to assess prior evidence before
mounting trials, and to provide access to treatment to
control arms and to the wider population. Given concerns
about misuse of cluster trial designs and the gap in the
literature and guidance for cluster trials in this region, we
conducted a systematic review to outline the use of cluster
trials involving children to determine whether cluster
trials in Kenya are used artificially to delay or limit chil-
dren’s access to treatment, or otherwise designed and im-
plemented to misinterpret or avoid obligations held under
children’s right to health.Review
Methods
Trials were eligible for review if published between 1
January 2003 and 28 February 2014, if publications re-
ported using cluster randomization, if trials involved
children aged between zero and eighteen, and if study
sites were located in Kenya. The time period was se-
lected to reflect human rights trends in cluster trials
since Treatment Action Campaign was initiated in 2002,
and also to account for CONSORT statement: extension
to cluster randomized trials (CONSORT cluster state-
ment), which published additional guidelines for cluster
trials in 2004 [24]. Involvement is defined as contact
with children either by collecting data specifically about
children or administering or targeting interventions to
children. Although expectant women were involved in
the key case motivating this review, the intervention in
question was primarily intended to benefit newborn
children; the case was based on the government
intention to deprive children of access to the interven-
tion, made on behalf of children and the claim was suc-
cessful based on children’s right to health. This review
focused on cluster trials assessing interventions primar-
ily targeting children; studies assessing interventions
targeting only the health of expectant women or postna-
tal mothers (and not their offspring) were excluded.
Studies that had only registered and not yet started col-
lecting data or published their trial protocol by 28 Feb-
ruary 2014 were excluded. Electronic searches were
done on two key search locations, PubMed and Clinical-
Trials.gov websites. Fourteen studies were eligible for
review. Eligible studies were read and coded for each of
the review measures below, information extracted and
input into Table 1 by the first author. The second author
reviewed this table and randomly sampled review mea-
sures and publications.
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Review measures are factors that affect the right to
health raised by the design and implementation of clus-
ter trials involving children and were developed and vali-
dated by the first and second authors. These measures
are:
1) Rationale for cluster trial design
2) Interventions
3) Pre trial standard of care
4) Prior evidence of efficacy and effectiveness
5) Results and conclusions
6) Post-trial access to interventions
7) Government involvement
With the CONSORT cluster statement, cluster trials are
required to report their rationale for using cluster
randomization and only a narrow range of circumstances
are ethically acceptable. Rationale can also indicate
whether cluster trial designs are misused, whether ethical
implications are well understood and requirements under
children’s special right to health will follow from the study
rationale. Under children’s special right to health, cluster
trials are required to offer a comparable standard of care
to that available in the region, and where there are ques-
tions about accessibility of stated standards, cluster trials
are required to show prior justification for developing a
standard of care lower than available standards and to
show that government had duly considered this interven-
tion and the justification to offer this. This may include
evidence of unmet standards.
Cluster trials are also required under children’s spe-
cial right to health to show any prior evidence of effi-
cacy and effectiveness of their interventions to show
that clinical equipoise had obtained in the trial and
further research was warranted. The results and con-
clusions of the cluster trials indicate the end point
of trials, which allow for a retrogressive review of
cluster trial rationale, and for further review of de-
signs. In addition, children’s special right to health
imposes obligations on governments to implement
cluster trials in the wider population and to imple-
ment positive results in control arms. Government
involvement in cluster trials is an important indicator
of where obligations should fall.
Results
Table 1 Factors affecting children’s right to health in
cluster randomized trials in Kenya between January 2002
and 28th February 2014.
Fourteen cluster trials were conducted in Kenya in-
volving children and published between January 2002
and September 2013. Gewa et al. [25] was published in
2013. Three studies, Patel et al. [26], Suchdev et al. [27]and Freeman et al. [28] were published in 2012. Four
studies, Opondo et al. [29], Zurovac et al. [30], Kangwana
et al. [31] and Ayieko et al. [32] were published in 2011.
The remaining six studies were published before 2010
and as far back as 2003, including Brooker et al. [33],
Skarbinski et al. [34], Clarke et al. [35], Crump et al. [36],
Desai et al. [37] and Philips-Horward et al. [38].
Six out of fourteen cluster trials looked into various
aspects of malaria. Four studies involved only children
and of these, two studies focused solely on malaria.
Kangwana et al. assessed retail sector delivery of subsi-
dized Artemether Lumenfantrine for treatment of mal-
aria in children aged between three and fifty-nine
months [31]. Zurovac et al. evaluated phone-text sup-
port to health workers as a means of improving adher-
ence to guidelines for malaria diagnosis and treatment
[30]. The other two studies investigated a combination
of health issues. Brooker et al. investigated whether mal-
aria screening and treatment combined with enhanced
literary instruction in primary schools could reduce mal-
aria related anemia and increase educational achieve-
ments, [33] and Clarke et al. looked at whether an
intervention delivering malaria preventative treatment
programs combined with education instruction in
schools could reduce malaria related school absence,
anemia and improve education performance in school
children [35].
Two of the six studies focusing on malaria provided
their intervention to both adults and children. Skarbinski
et al. assessed the impact of providing rapid diagnostic
testing kits in health facilities on the overall rate of
diagnosis and treatment of malaria in patients over
the age of five years, [34] and Philips-Howard et al.
assessed the impact of providing treated bed-nets
to communities on mortality in infants less than
60 months old [38].
Three out of fourteen cluster trials focused on nutri-
tion. Gewa et al. investigated whether providing food
supplementation to children in primary school led to re-
allocation of food at home [25]. Suchdev et al. piloted a
community based program distributing micronutrient
supplements targeting children between six and thirty
five months old to address anemia, [27] and Desai et al.
tested daily iron supplementation compared to other
modes for reducing anemia in children less than five
years of age [37].
Three out of fourteen cluster trials evaluated water
treatment, sanitation and or hygiene interventions. Two
of these three studies assessed school based interven-
tions: Patel et al. assessed the impact of an intervention
providing a hygiene curriculum, handwashing and
drinking water stations in schools on hygiene practices,
diarrhea and acute respiratory illness, [26] and Freeman
et al. evaluated whether providing water, sanitation,
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Table 1 Factors affecting children’s right to health in cluster randomized trials in Kenya, January 2002 to February 2014 (Continued)
effect on boys (OR
0.88, 0.45 to 1.71).
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comparable benefit for
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students with any
illness (5% versus 7%
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Columns of results and conclusions are separated in this table to improve readability as some cluster trials reported complex results and some large cluster trials reported a larger amount of data.
Abbreviations: AL: Artemether Lumenfantrine; ACT: Artemisinin based combination therapy; AMF-m: Affordable Medicines Facilities-Malaria; CARE: Cooperation for Assistance and Relief Everywhere; CDC: Center for
Disease Control, United States; CI: confidence interval; GoK: Government of Kenya; HP: hygiene promotion; HW: health worker; IMCI: Integrated Management of Childhood Illnesses guidelines; IPT: intermittent
preventative treatment, for malaria; IST: intermittent screening and treatment, for malaria; Kshs: Kenyan shillings; KEMRI: Kenya Medical Research Institute; KNH: Kenyatta National hospital, main referral and teaching
hospital in Kenya.; LIC: low income countries; LSHTM: London School of Tropical Health and Medicine; MNP: micro nutrient supplement powder; MoHPS: Ministry of Health and Public Sanitation; MoE: Ministry of
Education; p: p value; PPB: Pharmacy and Poisons Board; PSI: Population Services International, an international health charity; NGO: non-governmental organization; RBM: roll back malaria program; RCT: randomized
control trials; RDT: rapid diagnostic test kit, for malaria; USAID: United States of America International Development; USD: United States dollar; WASH promotion: water and soap provision and hygiene promotion.;
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http://www.trialsjournal.com/content/15/1/287hygiene promotion in schools affected school attendance
[28]. The remaining study, Crump et al., investigated the
effect of household based flocculant disinfection of water
on mortality and diarrhea in children less than two years
of age in areas using water from turbid sources [36].
Two of out of fourteen cluster trials focused on
pediatric guidelines in health facilities. Ayieko et al.
evaluated whether multifaceted implementation of
guidelines in rural district hospitals improved pediatric
care, [32] and Opondo et al. was a secondary analysis of
data focusing on a specific guideline to reduce inappro-
priate use of antibiotics to treat non-bloody diarrhea in
children [29].
Rationale for cluster trial design
Only two out of fourteen cluster trials clearly reported
their reason for using cluster trial design. Ayieko et al.
assessed an intervention providing multifaceted imple-
mentation of pediatric care guidelines in district hospi-
tals and reported their intervention was intended for
groups so cluster randomisation was logistically con-
venient [32]. Brooker et al. evaluated the effect of inter-
vention providing intermittent malaria screening and
treatment combined with enhanced literacy instruction
to reduce malaria related anemia. Brooker et al., used
school clusters to reduce contamination among partici-
pants [33]. Cluster trials are often used instead of trad-
itional trials to create distance between the subjects of
the trials to reduce the possibility that members of one
cluster adopt the behavior of members in the compari-
son cluster by ‘contamination’ and so damage the results.
The remaining twelve cluster trials did not clearly report
why they used cluster randomization. However, we in-
ferred from published information in all cluster trials
that cluster randomization was logistically convenient
and would reduce contamination.
Standard of care before trial
a. All trial arms receive conditions comparable to
standard of care
Ten of fourteen studies offered their intervention
arms a standard of care similar to or better than the
government’s stated regional standard, while clusters
in their control arms received the stated regional
standard of care.
Gewa et al. offered a school based feeding program
in three arms, while children in one arm received
the regional standard which was not to receive food
supplementation [25]. Patel et al. offered a drinking
water, handwashing and hygiene promotion
intervention in intervention schools, where the
regional standard was no intervention, which served
for control schools [26].Ayieko et al. and Opondo et al. offered a full
multifaceted implementation of pediatric guidelines
in rural district hospitals including hospital
assessments, longer training, more supervision, face-
to-face feedback and support from a facilitator
[29,32]. Control arm hospitals received an active
control involving adapted guidelines, less training,
written feedback, less facilitation and less supervision.
The active control was still better than the government
approach to implementing guidelines, which relied on
opportunistic training and mainly adapted written
guidelines.
For their intervention arm, Zurovac et al. sent daily
text message reminders to health workers containing
key points of guidelines on pediatric malaria
diagnosis and treatment [30]. Health workers in the
control arm did not receive any intervention, which
was the regional standard of care.
Brooker et al. offered schools in the intervention
arm enhanced literacy instruction and malaria
prevention and treatment, neither intervention was
available in the region [33]. Schools in the control
arms received either the literacy component, or
intermittent screening and treatment component, or
did not receive any component of the intervention.
Skarbinksi et al. offered rapid diagnostic test kits for
malaria to health facilities in their intervention arm
[34]. All arms received training, guidance and
supervision on how to use rapid diagnostic kits, the
new national malaria protocol as well as training on
the use of the protocol. Health facilities in the
control arm did not receive extra kits from the
study, but continued to offer patients the regional
standard of care, which was eventually to have at
least one diagnostic equipment item per health
facility.
Clarke et al. offered schools in their intervention
arm intermittent malaria prevention to pupils and
one-day teacher training on education methods,
control schools did not receive any intervention and
neither intervention was available in the region [35].
The standard of care in Desai et al. was a short
course of unsupervised iron supplementation which
was given together with presumptive malaria
treatment [37]. All four arms received a comparable
standard of care involving one of the following
interventions; daily-supervised iron supplementation,
daily-unsupervised iron supplementation, twice
weekly supervised, or twice weekly unsupervised
iron supplementation. Philips-Howard et al. offered
their intervention arm treated bed-nets but their
control arm did not receive bed-nets during the
study, as was the standard policy in the region in
1998/9 when the study recruited [38].
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local standard of care
Two out of fourteen cluster trials offered the control
arm less than the stated standard of care. Freeman
et al. selected only schools that did not meet the
government policy for latrines provision [28].
Schools in three intervention arms either received
the full intervention consisting of hygiene promotion
component, teacher training, and sanitation
component (although the number of latrines was
limited whatever the size of the school), or a partial
intervention consisting of either the hygiene
promotion component and teacher training, or only
teacher training. One arm did not receive any
component, which was less than the stated standard
of care to provide a certain number of latrines,
based on the size of the school, but was a reality for
the selected schools and for many schools in the
region.
Crump et al. offered either flocculant disinfectant or
a commercially available product based on sodium
hypochlorite for household based water treatment in
either of two arms. Households in the third arm
continued with traditional water treatment and
storage practices involving fetching water from
ponds and rivers, cloth filtration and decantation.
The government had a policy to provide clean
drinking through a scheme of various agencies, for
which there would have been a standard set up
charge as well as user fees, but less than half of rural
households and two thirds of urban households had
been reached [36]. Children in the control
‘traditional’ treatment arm were not assisted in
accessing this basic public service or any other
alternatives available in the region.
c. Intervention arms receiving conditions worse than
the local standard of care
Two out of fourteen studies evaluated an
intervention that was arguably inferior to the
government policy or local standard of care while
their control arms received the standard of care.
Kangwana et al. offered their intervention arm
subsidized pediatric Artemether Lumenfantrine
through retail outlets and requiring parents to pay a
small amount for it, without professional diagnosis
by a health worker, and sometimes being dispensed
without a prescription or pharmacists’ advice [31].
Under the government’s stated standard of care,
children attend a local healthcare facility and are
assessed by a professional health worker who
prescribes free Artemether Lumenfantrine if
required.
In Suchdev et al., vitamin A and iron were ostensibly
available in public health facilities but the trialoffered micronutrient supplements with vitamin A
and iron that cost two Kenyan shillings per sachet
and were sold by community based vendors [27].
Children in the intervention arm may have received
worse care than the government standard because
they paid for micronutrient supplements although
this cost may have been offset by cost of travel to
public health facilities. However, children in the
intervention arm did not receive attention from a
health worker whereas children in the control arm
received attention from a health worker and free
supply of some micronutrients from public health
facilities where available, although availability was
inconsistent.Prior evidence of efficacy or effectiveness of test
interventions
a. Interventions with prior evidence of efficacy and
some evidence of effectiveness
Three out of fourteen cluster trials reported prior
clear evidence of efficacy and some evidence of
effectiveness for their interventions. Freeman et al.
reported that previous randomized control trials
showed water treatment, sanitation and hygiene
promotion intervention in schools in low-income
countries reduced pupils’ absence and a similar
intervention in homes improved the health status of
children under five [28]. It was not known how
components of this intervention worked together or
whether there was a gender specific effect.
Crump et al. reported several studies showing
efficacy of flocculant disinfectant in developing
countries, and one Kenyan study showed flocculant
disinfectant was more effective than sodium
hypochlorite in treating turbid water and for
pathogens resistant to chlorine [36]. It was not clear
how these effects would translate specifically to
households. Philips-Howard et al. assessed the
effectiveness of providing treated bed-nets to
households and reported a previous randomized
control trial in sub Saharan Africa showing treated
bed-nets reduced all-cause mortality in children
under five by seventeen percent, and a Tanzania
program estimated a twenty-seven percent increase
in survival in children under five, but had no
information about the effect of treated bed-nets on
mortality in very young children in areas with high
malaria transmission pressure [38].
b. Interventions with prior evidence of efficacy and no
prior evidence of effectiveness
Two of fourteen cluster trials reported clear
evidence of efficacy but little or no evidence of
effectiveness for their interventions. Suchdev et al.
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supplements using social marketing and had
evidence micronutrient powders worked as well as
prophylactics at reducing anemia, iron and vitamin
A deficiency in young children [27]. Skarbinski et al.
evaluated the effect of providing rapid diagnostic
test kits for malaria in local health facilities, which
was established to be faster and required fewer
resources than traditional microscopy testing, but
had not been previously used in Kenya and at the
time were being introduced into the public
healthcare system [34].
c. Intervention with prior evidence of efficacy but
mixed evidence on effectiveness
Six out of fourteen cluster trials reported that
interventions had clear evidence of efficacy as well as
mixed evidence on effectiveness. Patel et al.
investigated whether a school based handwashing,
water treatment and provision, and hygiene
promotion intervention improved hygiene practices
and reduced illness and reported one systematic
review and a meta-analysis showed handwashing with
soap and household water treatment reduced illnesses
and diarrhea but reported difficulties implementing
handwashing and water treatment practices [26].
Three studies in developing countries showed similar
interventions led to behavior change in hygiene
practices in children and parents, and four school based
Kenyan studies showed similar interventions led to
reduction in school absenteeism. However, they reported
a lack of evidence showing a direct impact on health.
Gewa et al. investigated whether an intervention
providing school based food supplementation led to
reallocation of household foods among household
members [25]. Three studies in low income
countries showed school based food supplementation
programs increased children’s overall energy intake
while one study showed household based food
supplementation program led to redistribution of food
to non-intended targets. Opondo et al. and Ayieko
et al. assessed an intervention providing multifaceted
implementation of pediatric guidelines in rural
district hospitals on pediatric admission care [29,32].
These well established guidelines were developed by
the World Health Organization for use by health
facilities in restricted resources but few low-income
countries had implemented or assessed these
established guidelines, although it was theorized
that multifaceted implementation in comparison to
traditional implementation increased uptake of
guidelines.
Kangwana et al. reported pilot programs providing
subsidized Artemether Lumenfantrine in Uganda
and Tanzania increased uptake with good adherenceto subsidized prices and reduced the use of old
malaria treatment regimens, while studies in West
African testing similar programs showed
inconsistent availability of subsidized Artemether
Lumenfantrine and low adherence to recommended
retail prices [31]. Desai et al. assessed the impact of
an intervention providing supervised daily iron
supplementation compared to other modes of
supplementation to treat childhood anemia [37]. A
1999 meta-analysis showed supervision had an
effect, and that daily dosing was more efficacious
than weekly dosing in pregnant women, but did not
show conclusive results in children or adolescents.
Desai et al. reported that a study with aboriginal
children published after the meta-analysis showed
twice weekly supervised supplementation was better
than unsupervised daily iron supplementation in
reducing anemia.
d. Interventions with prior partial or weak evidence of
efficacy
Three out of fourteen cluster trials reported their
intervention had partial or existing but weak
evidence of efficacy. Brooker et al. assessed whether
an intervention combining school based intermittent
malaria treatment and enhanced literacy instruction
improved educational achievement [33]. A previous
Sri Lankan study showed school based malaria
treatment reduced anemia and improved exam
scores, and a previous Kenyan cluster trial showed a
similar intervention reduced anemia but had no
effect on educational scores.
Clarke et al. evaluated whether school based malaria
prevention led to improved educational achievement
[35]. A previous study showed providing
intermittent malaria prevention in schools led to
lower rates of anemia and malaria, fewer clinical
attacks and reduced malaria related absenteeism.
Three African studies showed similar interventions
reduced malaria prevalence and led to improved
cognitive abilities. There was no evidence to link
reduction in malaria related school absenteeism and
malaria related anemia to improvements in
cognition and educational performance.
Zurovac et al. investigated whether an intervention
sending reminder text messages to health workers’
mobile phones improved their adherence to
guidelines on malaria diagnosis and treatment for
young children [30]. Two previous Kenyan
randomized control trials evaluated text messages
sent from health workers to HIV/AIDS patients to
improve patients’ adherence to treatment regimens
but there was no data on how this approach might
improve adherence among professional health
workers.
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a. Positive results
Five of the fourteen cluster trials reviewed reported
positive results for their interventions. Opondo et al.
did a regression analysis of data collected by Ayieko
et al. and found the odds ratio of children receiving
inappropriate antibiotics for non-bloody diarrhea in
control hospitals compared to intervention hospitals
was 0.30 with 95% confidence interval (CI) 0.09 to
1.02) [29].
Zurovac et al. showed that sending text messages to
health workers improved their adherence to malaria
guidelines [30]. Effects for four treatment tasks and
five out of six dispensing and counseling tasks
showed an improvement of 21.4% with 95% CI 9.0
to 33.7, P-value = 0.0007 in the short term, and
23.7% with 95% CI 11.6 to 35.7, P = 0.0001 at six
months. There was a smaller effect when all tasks
were measured, 10.3%, 95% CI 4.0 to 16.6 P =
0.0013 in the short term and 11.3% at six months,
95% CI, 5.1 to 17.6, P = 0.0004.
Kangwana et al. found retail delivery of subsidized
Artemether Lumenfantrine resulted in 35.9% of
children receiving Artemether Lumenfantrine on the
same day or next day in the intervention arm
compared to 14% of children in control arms given
95% CI, P = 0.0002 and adjusted P = 0.0001 [31].
Tibamal, the intervention brand, accounted for 63%
of Artemether Lumenfantrine sold. Ninety-three
percent of Tibamal was bought at recommended
price with standard deviation of 5.3% and there was
no significant difference in adherence to dosages.
Desai et al. found daily iron supplementation was
better than twice weekly supplementation in
supervised clusters [37]. The mean difference at 6
weeks was 4.2 g/L and 4.4 g/L with 95% CI at twelve
weeks. In unsupervised groups, no mean difference
was noted at 6 weeks but at 12 weeks, a difference
of 3.4 g/L P = 0.02 95% CI was noted between arms.
Philips-Howard et al. found treated bed-nets
provided a protective effect of 26% in children aged
between 1 and 11 months and 14% efficacy in
children aged 12 and 59 months for 95% CI [38].
b. Mixed results
Seven of fourteen cluster trials reported mixed
findings. Gewa et al. found school based food
supplementation did not significantly reduce
quantity or quality of children’s intake at home but
significantly reduced protein intake in parents in the
vegetarian arm [25].
Patel et al. found hygiene promotion increased
handwashing and reduced all illness by 5% versus
7%, with Estimated Difference in Median (EDM) 3%,90% CI 4 to 1%, and reduced acute respiratory
illness at first round by 2 versus 3% with EDM −2%,
90% CI −3 to −1%, and found similar rates of illness
during the second round of measurements, but did
not observe any effect on diarrheal diseases during
both rounds [26].
Suchdev et al. found community based marketing of
micronutrient supplements significantly reduced
prevalence of iron deficiency by a difference of 14%,
P = 0.001, noted a smaller reduction in vitamin A
deficiency, difference of 5%, P = 0.01, and in anemia
prevalence with 7.1% absolute difference, P = 0.1
[27].
Freeman et al. evaluated the impact of water
treatment, hygiene promotion and sanitation in
schools on attendance and by gender and found
water treatment and hygiene promotion had no
significant impact on overall absence even when
sanitation was added [28]. However, their
intervention had a gender specific effect: hygiene
promotion and water treatment alone reduced the
odds of absence in girls by 58%, odds ratio of 0.42,
0.21 to .085, but no effect on boys, odds ratio of
0.88, 0.45 to 1.71. The addition of sanitation showed
comparable benefits for girls, odds ratio of 0.47, 0.21
to 1.05 but no effect for boys, odds ratio 0.98, 0.52
to 1.87.
The study by Ayieko et al. involved a multifaceted
implementation of pediatric guidelines and observed
general improvements across a total of 18 outcome
measures including task/process and structure
indicators to varying degrees [32]. For instance,
completion of admission tasks was higher in
intervention hospitals, uptake of recommended
therapeutic practice was higher in intervention
hospitals compared to intervention hospitals and the
proportion of children receiving inappropriate doses
of drugs was lower in intervention hospitals.
Clarke et al. provided intermittent preventative
malaria treatment and an education intervention and
found prevalence of malaria dropped in intervention
schools to 6.3% and to 12.6% in the control schools,
with adjusted risk ratio 0.52, 95% CI 0.29 to 0.93;
P = 0.028, noted a mean increase in performance in
two classroom based measures, in code transmission
of 6.06%, 95% CI 2.83 to 9.27, P = 0.0007 and in
counting test scores 1.80%, 0.19 to 3.41, P = 0.03,
but found their intervention had no effect on
educational achievement and on 2 other classroom
scores [35].
Crump et al. found their intervention providing
household based flocculant disinfectant significantly
reduced diarrhea prevalence in children under 2,
and flocculant disinfectant reduced prevalence by
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sodium hypochlorite reduction in prevalence by
17%, −34 to 4 compared to control practices [36]. In
addition, flocculant disinfection significantly lowered
turbidity to eight nephelometric units compared
with 55 nephelometric units in other water
treatment methods. There were significantly fewer
deaths in households not using traditional methods,
relative risk of death 0.58, P = 0.036, but the
difference between either method was not
significant, with 0.53 relative risk in flocculant
disinfection, P = 0.052 compared to relative risk of
0.61, P = 0.108 in households using sodium
hypochlorite.
c. Negative results
Two out of fourteen studies reported negative
results. Brooker et al. reported intermittent malaria
screening and treatment did not significantly affect
anemia and malaria prevalence, classroom attention
scores and educational achievement in older
children, but noted an apparent negative effect on
spelling scores in the younger class and on
arithmetic scores [33].
Skarbinksi et al. found providing rapid diagnostic
tests for malaria in health facilities increased their
use from 35% to 46%, and reduced the use of
traditional tests from 38% to 8%, but providing these
kits did not change overall testing rate if measured
by all methods [34]. However, provision of rapid
diagnostic test kits reduced the use of clinical
diagnosis of malaria to prescribe Artemether
Lumenfantrine by 36%, P = 0.03. The study
explained that these results were obtained because
health workers in the study inappropriately
substituted traditional tests for the rapid diagnostic
test instead of using rapid diagnostic test kits in
addition to other methods.
Post-trial access to beneficial interventions
Five out of fourteen trials planned to offer their inter-
ventions, if successful, to their control clusters. The
remaining nine studies did not report any arrangements
for expanded access to control groups or rollouts. Only
one of the five trials planning post-trial access was a
pilot program and rolled out their intervention in the re-
gion. Suchdev et al. expanded provision of community
based marketing of micronutrient supplements to in-
clude control villages after the trial (without promoting
available free public services) [27].
The other four trials planning post-trial access were not
pilot studies but still expanded access to control arms. Patel
et al. rolled out their hygiene promotion and water and
soap provision intervention to schools in the control arm.
Brooker et al. planned, but did not implement intermittentmalaria prevention and treatment and enhanced literary in-
struction in the control group, as the trial did not obtain
positive results [33]. Freeman et al. provided latrines to
schools in control arms after the trial [28]. Similarly, Philip-
Howards et al. provided treated bed-nets to control arm
families [38].
In two out of nine studies without prior arrangements
for post-trial access to interventions, access for the wider
population increased independent of results and of clus-
ter trials. Kangwana et al. did not offer post trial access
to subsidized Artemether Lumenfantrine but coverage
rose to 60% during and soon after the trial as a result of
parallel and independent government policy [31]. In
Skarbinksi et al. the government independently in-
creased the provision of rapid diagnostic tests from 25%
to 50% according to plans during the trial as part of its
own strategy, the authors explained negative results of
the trial were caused by inappropriate use of tests during
the study [34].Government involvement
Nine out of fourteen studies either used public facilities
such as health facilities or schools, or involved public offi-
cials mainly health workers during design and implemen-
tation. Five out of fourteen studies reported developing
their intervention with public sector partners. Zurovac
et al. developed their mobile text message content with
the Division of Malaria, Ministry of Health [30]. Kangwana
et al. consulted with Pharmacy and Poisons Board
who then gave permission for distribution of subsidized
Artemether Lumenfantrine in retail outlets, implemented
their trial through Division of Malaria, and collected data
from the retail sector through Population Services Inter-
national, a non-governmental organization [31]. In Ayieko
et al. and Opondo et al., the Ministry of Health and
pediatric teams assisted in multifaceted implementation of
pediatric guidelines [29,32]. For Brooker et al., Division of
malaria staff implemented intermittent malaria screening
and treatment component in schools and schoolteachers
implemented their literacy component [33].
Five out of the fourteen studies reported partnerships
with non-governmental organizations. Gewa et al. part-
nered with Child Nutrition Program, Freeman et al. was
embedded within a larger research project run by CARE,
(Cooperative for Assistance and Relief Everywhere) a
non-governmental organization [25]. Patel et al. and
Suchdev et al. were embedded within a wider project,
the Nyando Integrated Health Project, and Suchdev
et al. implemented their study through the Safe Water
and AIDS Project who also trained their community-
based marketers [26,27]. Kangwana et al. partnered
with Population Services International to implement their
intervention [31].
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Following the 2002 legal ruling in the Treatment Action
Campaign case, the main legal question addressed in this
review was whether the 14 cluster trials published since
2002 were warranted from the perspective of the child’s
special human right to health which should guarantee
access to treatment in the face of prior evidence sup-
porting interventions that offered basic or life saving
healthcare. State parties now have a clear negative duty
not to limit access to proven and funded medicines by
artificially restricting access to further ‘pilot’ in certain
areas, or by extension, run cluster trials.
As many as 11 of the 14 trials raised issues of human
rights to health, and this is especially important as all
had ethics approval from various ethics review commit-
tees, while 9 trials involved the use public facilities in re-
cruitment or in implementation, or were facilitated by
government bodies and thus were government spon-
sored or supported.
Four trials aimed to fill gaps in public provision of care
or in public infrastructure, but instead developed inter-
ventions that fell below the regional standard of care.
Two of these trials charged for malaria treatment or
micronutrient supplements so as to increase coverage
and distribution when government policy was to offer
them free of charge to children who attended public
health facilities and received attention from a health
worker. The other 2 remaining cluster trials failed to
provide control clusters with the standard expected of
public services, one failing to assist families with very
young children to access clean water despite a govern-
ment policy to do so, and the other failing to provide
sufficient numbers of latrines in control schools despite
government standards for latrines in schools. This is an
area for further development as it could be argued that
interventions can offer lower than the stated standard of
care if trials do not prevent participants from accessing
the local standard of care and where the local stated
standard of care is unmet. However, where the success
and need for an intervention depends on unmet local
standards, the right to health will require that such in-
terventions, are closely developed in partnership with
the relevant health authorities and that ethics review
committees are cognisant of the need for justification
for these interventions.
In three of eleven trials, there was a substantial amount
of prior evidence of benefit (both of efficacy and of effect-
iveness), making it unclear why the trials were thought to
be scientifically interesting or logistically necessary, and in
one case, substantial risks encountered by one control arm
were borne by very young children. These trials looked for
increasingly specific sub-group effects such as gender or
age, or sought to target the intervention to more specific
groups, such as households, which could raise the issue ofcircular justification for trials, just in order to evaluate ef-
fects by such specific group or cluster.
Despite clear guidance and a publishing requirement
under the CONSORT cluster statement in 2004, report-
ing of rationale for using cluster trial designs was gener-
ally inadequate across trials, this is problematic from a
human right to health perspective, as a violation of chil-
dren’s right to health by unnecessarily delaying full
realization, and as it reduces visibility of cluster trials
and children’s involvement and can thus lead to missed
opportunities for protection of children.
Although two thirds of trials appeared to be designed
to test effectiveness based on prior evidence of efficacy,
only one third of reviewed cluster trials reported little
prior evidence of efficacy, thus demonstrating a clear
need for research. Retrospectively, however, only about
half these trials fully corroborated prior evidence with
positive results which may cast doubt on the value of
prior evidence of efficacy. Ethics review committees
have the onus of examining prior evidence of efficacy
and effectiveness and it may be necessary to highlight
the need to report and scrutinize prior evidence sup-
porting cluster trials with children. It is still unclear
exactly what prior evidence justifies restricting access
through cluster trials, human rights law requires the
progressive realization of, if not full respect for, chil-
dren’s right to health, such that deviating from specific
government policies to develop interventions lower than
the stated or available standard of care or distribute
health resources simply for the purposes of research
(and sometimes regressing their realization in the
process) raises concern. Where government policy
states that a basic specific standard should be provided,
yet its ambition is not yet fully adopted or realized, hu-
man rights law would require effort and resources to be
better concentrated on furthering its ambition, espe-
cially in relation to essential services or basic healthcare
for children.
In other respects, there seems to have been a steady
improvement in design and implementation of cluster
trials with children in Kenya since 2002 from a right to
health perspective, as more recent trials offered active
control conditions and a few recent trials planned to roll
out successful interventions to control arms showing
that from a local perspective, independent and govern-
ment cluster trials recognize that control groups may
have a claim to benefits. More recently, the Constitution
of Kenya, 2010 clarified a minimum standard under chil-
dren’s right to health which is basic healthcare, a key
point for all stakeholders involved in cluster trials to
note, and informing classic debates in global research
ethics about trial conditions, and minimal or relative risk
by appealing to standards local authorities should meet
rather than what they provide in practice.
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A major challenge for children’s right to health in Kenya
identified in this review was that most trials were not
clearly justified since there was often prior evidence of effi-
cacy and some evidence of effectiveness for their interven-
tions. Some trials did not make provisions to implement
results, and even evaluated interventions which did not
seem to meet the local standard of care and minimum level
of basic care required by children’s special right to health.
In this regard, government should take greater heed of hu-
man rights perspectives, as they are often involved in design
and implementation, as well as bearing ultimate responsi-
bility for the ethics review of cluster trials. Government ob-
ligations are shared by stakeholders such as ethics review
committees and host and facilitating institutions while
other stakeholders such as international sponsors, inter-
national non-governmental organization and independent
cluster trials also have obligations primarily towards chil-
dren in control clusters as well as a wider obligation to
maximize opportunities for providing access to successful
results.
This review provides an essential outline of children’s
right to health in cluster trials based on the South
African legal precedent Treatment Action Campaign
and Others v Minister of Health and Others, and on
international and Kenya provisions for children’s right to
health. The obligations discussed here under the chil-
dren’s right to health are consistent with local ethical
guidelines, and may address gaps in ethical guidelines
and legal issues for cluster trials with children in sub
Saharan Africa.
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